Searchable abstracts of presentations at key conferences on calcified tissues
Bone Abstracts (2014) 3 PP378 | DOI: 10.1530/boneabs.3.PP378

ECTS2014 Poster Presentations Other diseases of bone and mineral metabolism (44 abstracts)

Zoledronic acid induces apoptosis on osteoblast and inhibits RANKL-induced osteoclast differentiation

Shin Saeng Lim 1 , In Sook Kim 1 & Soon Jung Hwang 1,


1Dental Research Institute, Seoul, Republic of Korea; 2Oral and Maxillofacial Surgery, Seoul, Republic of Korea.

Bisphosphonates (BPs) are widely used as antiresorptive drugs. However, one of most potent BPs, zoledronic acid (ZA) can cause BP-related osteonecrosis of the jaws (BRONJ) with a poorly understood pathophysiology. The aim of this study was to find a clue for the development of BRONJ by evaluating the cytotoxic effects of ZA on osteoblasts and examining the action mechanism of ZA on osteoclast differentiation. Jaw bone osteoblasts (JB-OBs), long bone osteoblasts (LB-OBs), and bone marrow macrophages (BMMs) were isolated from Balb/C mouse. Osteoblasts were treated with ZA at increasing doses (0.01, 0.1, 1, 5, 10, 50, and 100 μM) for 7 days. The cytotoxic effects of ZA appeared from day 3 at high dose of 50 and 100 μM with increase of apoptosis in both types of osteoblasts, of which JB-OBs were more sensitive than LB-OBs. Western blotting showed increased expression of apoptotic markers, p21 and p53 at 50 μM of ZA. BMMs were pretreated with various concentrations (0, 0.01, 0.1, and 1 μM) of ZA for 1 h before stimulating with receptor activator of nuclear factor-κB ligand, the osteoclast differentiation factor. ZA attenuates osteoclast differentiation by suppressing the development of multinuclear cells. ZA decreased the transcriptional expression of osteoclast transcription factor, NFATc1 as well as ATP6v0d2 gene which was involved in cell-cell fusion during osteoclastogenesis. These findings revealed that ZA at high dose induces apoptosis, more apparently in JB-OBs than LB-OBs, and attenuates osteoclast differentiation, suggesting that chronic administration of ZA might exert adverse effect on bone metabolism.

Volume 3

European Calcified Tissue Society Congress 2014

Prague, Czech Republic
17 May 2014 - 20 May 2014

European Calcified Tissue Society 

Browse other volumes

Article tools

My recent searches

No recent searches.